髂股动脉硬化闭塞症金属裸支架置入术后疗效评价

doi:10.12117/jccmi.2020.08.004

Abstract
Figure/Table
References (0)
Related Citation (15)

Download: PDF (0 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective: To evaluate the medium- and long-term effect of bare metal stent implantation in treatment of lower extremity arteriosclerosis obliterans. Methods: Six-eight patients with iliac or femoral arteriosclerosis obliterans from January 2012 to December 2017 in our hospital were reviewed. Six-eight cases of arteriosclerosis obliterans were classified according to the TransAtlantic Inter-Society Consensus Ⅱ(TASC Ⅱ) document, including 6 cases in stage A, 27 cases in stage B, 24 cases in stage C and 11 cases in stage D. The Rutherford classification included 5 cases of grade 2, 20 cases of grade 3, 22 cases of grade 4, and 21 cases of grade 5. Results: The 1-year, 3-year, and 5-year primary patency rates were 76.1%, 59.6%, and 33.9%, respectively. The Rutherford grade was reduced in 58 patients. The postoperative Rutherford grade was: 10 cases of grade 0, 38 cases of grade 1, 8 cases of grade 2, 7 cases of grade 3, 2 cases of grade 4, 3 cases of grade 5. Conclusion: The bare metal stent implantation has a good effect on the patients with iliac or femoral arteriosclerosis obliterans in the medium and long term, and can effectively improve the quality of life of patients.

Key words： Arteriosclerosis obliterans Stents Radiology, interventional

Received: 08 June 2020

PACS:	Ｒ543.5
	Ｒ815

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	MEI Kai1
	CHEN Lei2
	SUN Tao2
	YAN Liang-liang2
	ZHENG Chuan-sheng2

Cite this article:

MEI Kai1,CHEN Lei2,SUN Tao2, et al. Evaluation of the effect of bare metal stent placement in the treatment of iliofemoral arteriosclerosis obliterans[J]. JOURNAL OF CHINA MEDICAL IMAGING, 2020, 31(8): 543-543.

URL:

http://www.jccmi.com.cn/EN/10.12117/jccmi.2020.08.004 OR http://www.jccmi.com.cn/EN/Y2020/V31/I8/543

[1]Fowkes FG, Rudan D, Rudan I, et al. Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis[J]. Lancet, 2013, 382(9901): 1329-1340. [2]Conte SM, Vale PR. Peripheral Arterial Disease[J]. Heart Lung Circ, 2018, 27(4): 427-432. [3]Norgren L, Hiatt WR, Dormandy JA, et al. Inter-Society Consensus for the Management of Peripheral Arterial Disease(TASC Ⅱ)[J]. J Vasc Surg, 2007, 45(Suppl S): S5-67. [4]刘文导，冯柳迁，孟凡喆，等. 下肢动脉硬化闭塞症介入治疗效果及影响术后复发因素分析[J]. 介入放射学杂志，2017，26（6）：514-517. [5]Ratnam L, Raza SA, Horton A, et al. Outcome of aortoiliac, femoropopliteal and infrapopliteal endovascular interventions in lesions categorised by TASC classification[J]. Clin Radiol, 2012, 67(10): 949-954. [6]李艳奎，吴义生，张小明. TASC-D型下肢动脉硬化闭塞症腔内治疗现状[J]. 介入放射学杂志，2015，24（6）：544-547. [7]Adam DJ, Beard JD, Cleveland T, et al. Bypass versus angioplasty in severe ischaemia of the leg(BASIL): multicentre, randomised controlled trial[J]. Lancet, 2005, 366(9501): 1925-1934. [8]李京雨，刘涛，路军良，等. 介入治疗复杂下肢动脉硬化闭塞症技术与疗效分析[J]. 中华放射学杂志，2011，45（10）：960-963. [9]Lucatelli P, Cini M, Tommasino G, et al. Use of the Gore Tigris Vascular Stent in Advanced Femoropopliteal Peripheral Arterial Disease[J]. J Vasc Interv Radiol, 2018, 29(5): 614-622. [10]Ding Y, Zhou M, Wang YG, et al. Comparison of Drug-Eluting Stent With Bare-Metal Stent Implantation in Femoropopliteal Artery Disease: A Systematic Review and Meta-Analysis[J]. Ann Vasc Surg, 2018, 50: 96-105. [11]Stavroulakis K, Torsello G, Manal A, et al. Results of primary stent therapy for femoropopliteal peripheral arterial disease at 7 years[J]. J Vasc Surg, 2016, 64(6): 1696-1702. [12]Mohr PJ, Oyama JK, Luu JT, et al. Clinical outcomes of endovascular treatment of TASC-Ⅱ C and D femoropopliteal lesions with the Viabahn endoprosthesis[J]. Cardiovasc Revasc Med, 2015, 16(8): 465-468. [13]Lee SC, Joh JH, Chang JH, et al. Hybrid Treatment of Multilevel Revascularization in Patients With Peripheral Arterial Disease—A Multi-Centre Study in Korea[J]. Vasa, 2018, 47(3): 235-241. [14]Lu L, Mackay DF, Pell JP. Meta-analysis of the association between cigarette smoking and peripheral arterial disease[J]. Heart, 2014, 100(5): 414-423. [15]Leibson CL, Ransom JE, Olson W, et al. Peripheral arterial disease, diabetes, and mortality[J]. Diabetes Care, 2004, 27(12): 2843-2849. [16]Selvin E, Marinopoulos S, Berkenblit G, et al. Meta-analysis: Glycosylated Hemoglobin and Cardiovascular Disease in Diabetes Mellitus[J]. Ann Intern Med, 2004, 141(6): 421-431.